ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

311
Analysis
Health Care • China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
•23 Sep 2024 00:18

Merger Arb Mondays (23 Sep) - Henlius, GA Pack, China TCM, Canvest, Trancom, Fuji Soft, Platinum

This week, the highest gross spreads are Canvest (8.6%), Shinko Electric (7.2%), GA Pack (6.9%), Henlius (6.7%), China TCM (5.7%), Capitol Health...

Logo
532 Views
Share
•16 Sep 2024 00:41

Merger Arb Mondays (16 Sep) - China TCM, Canvest, GA Pack, Raysum, Seven & I, Fuji Soft, Dyna-Mac

This week, the highest gross spreads are HEC Pharma (139.1%), Raysum (94.2%), Canvest (8.4%), GAPack (7.3%), China TCM (6.5%), Henlius (6.3%),...

Logo
668 Views
Share
•10 Sep 2024 08:55

Shanghai Henlius Biotech (2696.HK) Privatization Update - Some New Information Worth the Attention

Fosun Pharma will make every effort to promote the success of privatization due to plans for Henlius internal integration with Fosun Pharma and...

Logo
691 Views
Share
•09 Sep 2024 00:39

Merger Arb Mondays (09 Sep) - Shinko, Fuji Soft, Pasco, GA Pack, CPMC, Latin Res, Capitol, PSC, Rex

This week, the highest gross spreads are HEC Pharma (116.0%), Canvest (8.4%), Shinko Electric (7.9%), Malaysia Airports (7.4%), GA Pack (6.9%),...

Logo
539 Views
Share
•08 Sep 2024 09:12

China Healthcare Weekly (Sep.8) - Fosun Pharma, Medical Device Outlook, Biotech Investment Criteria

Business model of medical devices is shifting, leading to potential underperformance. There's a gap between Chinese Biotech and top players....

Logo
470 Views
Share
x